Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Poor prognosis of constitutive γ-H2AX expressing triple-negative breast cancers is associated with telomere length.

Nagelkerke A, van Kuijk SJ, Martens JW, Sweep FC, Hoogerbrugge N, Bussink J, Span PN.

Biomark Med. 2015 Mar;9(4):383-90. doi: 10.2217/bmm.15.2.

PMID:
25808442
2.

γ-H2AX Foci in Peripheral Blood Lymphocytes to Quantify Radiation-Induced DNA Damage After 177Lu-DOTA-Octreotate Peptide Receptor Radionuclide Therapy.

Bussink J, Span PN.

J Nucl Med. 2015 Apr;56(4):501-2. doi: 10.2967/jnumed.115.153841. Epub 2015 Feb 26. No abstract available.

PMID:
25722454
3.

Biology of hypoxia.

Span PN, Bussink J.

Semin Nucl Med. 2015 Mar;45(2):101-9. doi: 10.1053/j.semnuclmed.2014.10.002. Review.

PMID:
25704383
4.

111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.

van Dijk LK, Boerman OC, Franssen GM, Kaanders JH, Bussink J.

J Nucl Med. 2015 Feb;56(2):287-92. doi: 10.2967/jnumed.114.148296. Epub 2014 Dec 31.

PMID:
25552666
5.

In response to "Histopathologic validation of 3'-deoxy-3'-(18)F-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice".

Troost EG, Hoeben BA, Laverman P, Bussink J, Oyen WJ.

Radiother Oncol. 2015 Mar;114(3):417-8. doi: 10.1016/j.radonc.2014.11.040. Epub 2014 Dec 12. No abstract available.

PMID:
25511411
6.

In-treatment assessment of response in locally advanced NSCLC: paving the way for personalized medicine.

Usmanij EA, Bussink J, de Geus-Oei LF.

Lung Cancer. 2014 Dec;86(3):374. doi: 10.1016/j.lungcan.2014.10.006. Epub 2014 Oct 17. No abstract available.

PMID:
25454200
7.

Improving chemoradiation efficacy by PI3-K/AKT inhibition.

Stegeman H, Span PN, Kaanders JH, Bussink J.

Cancer Treat Rev. 2014 Dec;40(10):1182-91. doi: 10.1016/j.ctrv.2014.09.005. Epub 2014 Oct 5.

PMID:
25312653
8.

The effect of carbogen breathing and nicotinamide added to standard (chemo)radiation treatment of advanced cervical cancer in Indonesia.

van Weelden WJ, Sekarutami SM, Bekkers RL, Kaanders JH, Bussink J, Gondhowiardjo S, Leer JW, Span PN.

Int J Gynecol Cancer. 2014 Nov;24(9):1628-35. doi: 10.1097/IGC.0000000000000271.

PMID:
25244605
9.

Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.

van Dijk LK, Boerman OC, Franssen GM, Lok J, Kaanders JH, Bussink J.

J Nucl Med. 2014 Oct;55(10):1665-70. doi: 10.2967/jnumed.114.141762. Epub 2014 Sep 18.

PMID:
25236350
10.

Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor model.

Meijer TW, Bussink J, Zatovicova M, Span PN, Lok J, Supuran CT, Kaanders JH.

PLoS One. 2014 Sep 16;9(9):e108068. doi: 10.1371/journal.pone.0108068. eCollection 2014.

11.

Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.

Schuurbiers OC, Meijer TW, Kaanders JH, Looijen-Salamon MG, de Geus-Oei LF, van der Drift MA, van der Heijden EH, Oyen WJ, Visser EP, Span PN, Bussink J.

J Thorac Oncol. 2014 Oct;9(10):1485-93. doi: 10.1097/JTO.0000000000000286.

PMID:
25170642
12.

The unfolded protein response as a target for cancer therapy.

Nagelkerke A, Bussink J, Sweep FC, Span PN.

Biochim Biophys Acta. 2014 Dec;1846(2):277-84. doi: 10.1016/j.bbcan.2014.07.006. Epub 2014 Jul 25. Review.

PMID:
25069067
13.

Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy.

Nagelkerke A, Bussink J, Geurts-Moespot A, Sweep FC, Span PN.

Semin Cancer Biol. 2015 Apr;31:99-105. doi: 10.1016/j.semcancer.2014.06.001. Epub 2014 Jun 14. Review.

PMID:
24933034
14.

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Cavalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P.

Nat Commun. 2014 Jun 3;5:4006. doi: 10.1038/ncomms5006.

15.

Therapeutic targeting of autophagy in cancer. Part I: molecular pathways controlling autophagy.

Nagelkerke A, Sweep FC, Geurts-Moespot A, Bussink J, Span PN.

Semin Cancer Biol. 2015 Apr;31:89-98. doi: 10.1016/j.semcancer.2014.05.004. Epub 2014 May 29. Review.

PMID:
24879905
16.

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma.

van de Schootbrugge C, Schults EM, Bussink J, Span PN, Grénman R, Pruijn GJ, Kaanders JH, Boelens WC.

BMC Cancer. 2014 Apr 11;14:252. doi: 10.1186/1471-2407-14-252.

17.

Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.

Heijmen L, Ter Voert EG, Punt CJ, Heerschap A, Oyen WJ, Bussink J, Sweep CG, Laverman P, Span PN, de Geus-Oei LF, Boerman OC, van Laarhoven HW.

Contrast Media Mol Imaging. 2014 May-Jun;9(3):237-45. doi: 10.1002/cmmi.1564.

PMID:
24700751
18.

Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.

Stegeman H, Rademakers SE, Span PN, Takes RP, van der Kogel AJ, Kaanders JH, Bussink J.

Head Neck. 2014 Sep;36(9):1288-95. doi: 10.1002/hed.23446. Epub 2013 Nov 6.

PMID:
24668936
19.

Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinoma.

Nagelkerke A, Sweep FC, Stegeman H, Grénman R, Kaanders JH, Bussink J, Span PN.

Head Neck. 2014 Mar 14. doi: 10.1002/hed.23693. [Epub ahead of print]

PMID:
24634103
20.

Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.

Hoeben BA, Starmans MH, Leijenaar RT, Dubois LJ, van der Kogel AJ, Kaanders JH, Boutros PC, Lambin P, Bussink J.

BMC Cancer. 2014 Feb 26;14:130. doi: 10.1186/1471-2407-14-130.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk